Onychomycosis Treatment Market Insights, Potential Business Acquisitions, Revenue Analysis - 2018 – 2028 Healthcare, Pharmaceuticals & Medical Devices Report Id : REP-GB-1279 Status : Published Category : Healthcare, Pharmaceuticals & Medical Devices ©2015 Future Market Insights, All Rights Reserved About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Customized Research Syndicated Research Investment Research Social Media Research Customized Research Syndicated Research Investment Research Social Media Research Sector Coverage Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Subscription Information For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: [email protected] ©2015 Future Market Insights, All Rights Reserved 2 Research Methodology (1/2) Systematic Research Approach 1 Market profiling 2 Formulating discussion guide 3 Developing list of respondents 4 In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. FMI formulates a detailed discussion guide to conduct expert and industry interviews FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts Data collection FMI conducts interviews with industry experts, industry players, distributors and retailers Data validation Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data 5 6 Data analysis Insights 7 Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry FMI delivers industry insights and information in the required format (PDF) Data Collection Research & Intelligence Data Filter & Analysis Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain Actionable Insights A Primary Research B SOLUTION Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments Primary Research # Linkedin Zoominfo Salesforce Avention Business Solution Desk Research C Key industry experts Channel study Developments Market dynamics Products Conclusions Company Analysis Secondary Research # Company websites Company annual reports White papers Financial reports Paid Publications# Factiva GBI Genios Meltwater # includes sources of databases ©2015 Future Market Insights, All Rights Reserved 3 Onychomycosis Treatment Market Analysis The Top Five Players Hold Around 43.9% of the Global Onychomycosis Treatment Market The onychomycosis treatment market is a moderately consolidated market, with the top five leading players holding around 43.9% market share. These players include Valeant Pharmaceuticals Inc., Galderma S.A., Novartis AG, Pfizer, Inc., and Moberg Pharma AB. All these manufacturers have strong sales channels throughout the globe. Jublia, manufactured by Valeant Pharmaceuticals Inc., and Diflucan, manufactured by Pfizer, Inc., were the key brands generating major revenue in the onychomycosis treatment market in 2017. Revenue from Loceryl, by Galderma, and Lamisil, by Novartis, have shown 2x growth in the past three years. Valeant Pharmaceuticals Inc. has launched a Direct-to-Consumer (DTC) marketing campaign, which includes print, digital, and television to boost the sales of Jublia. Increasing Elderly Population around the Globe Has Fuelled the Growth of the Onychomycosis Treatment Market According to WHO, age is the primary factor responsible for the development of onychomycosis, and the risk increases with age, particularly for persons aged >50 years. Approximately 80% to 85% of onychomycosis occurs in patients aged more than 50 years. Onychomycosis is reported to occur in 18.2% patients who are 60–79 years of age, compared to just 0.7% in patients younger than 19 years of age. Onychomycosis is common among the aged, with prevalence rates being as much as 20% in those aged 60 years, and 30% in those over 70 years of age. Thus, the increasing geriatric population is a major factor that is expected to drive growth of the onychomycosis treatment market during the forecast period. ©2015 Future Market Insights, All Rights Reserved 4 Onychomycosis Treatment Market Analysis Awareness Programmes by Non-profit Organizations to Fuel Sales of Onychomycosis Treatment Products Awareness programs are organized by non-profit organizations to spread awareness among people about onychomycosis treatment. For instance, the British Association of Dermatologist has circulated leaflets among patients that include complete guidance for onychomycosis treatment. Similar awareness programmers are expected to raise the awareness levels among patients in both, developed and developing economies, which will fuel the growth of the onychomycosis treatment market over the forecast period. Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1279 Lack of Skilled Medical Professionals May Deter Growth of the Onychomycosis Treatment Market Photodynamic therapy is the most advanced treatment option available for onychomycosis treatment. Skilled medical professionals are required to avoid any risk during the treatment period. But according to WHO, there will be a shortage of 12.9 million healthcare workers by 2035 across the globe. The demand for plastic surgeons has surged in the last few decades, whereas, the supply of plastic surgeons has declined. This demand-supply gap of plastic surgeons required to for photodynamic therapy for onychomycosis treatment may deter the growth of the onychomycosis treatment market. ©2015 Future Market Insights, All Rights Reserved 5 Onychomycosis Treatment Market Analysis Collaborations and Partnerships Are Key Strategies Being Followed by Leading Manufacturers in the Onychomycosis Treatment Market There is an increasing trend of partnerships being witnessed among leading players in the onychomycosis treatment market. Companies are entering into marketing and sales agreements for their promotion of their products. For instance, in 2014, Anacor Pharmaceuticals Inc. entered into an exclusive agreement with Novartis AG for the sales and marketing of their products in the U.S. market. Also, in 2013, Moberg Pharma signed a distribution agreement with Leosons International LLC for the marketing of the Kerasal nail product in the Middle East and North Africa. This trend is being followed by a majority of manufacturers in the onychomycosis treatment market throughout the globe. Request to View Methodology @ https://www.futuremarketinsights.com/askus/rep-gb-1279 Competitive Landscape The competition section of the onychomycosis treatment market report features the profiles of key players operating in the industry based on their market shares, differential strategies, product offerings, and marketing approach. Some of the key players featured in this report include Valeant PharmaceuticalsInc., Galderma S.A., Novartis AG, Pfizer, Inc., Moberg Pharma AB, Johnson & Johnson Services, Inc., Bayer AG, Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Medimetriks Pharmaceuticals, Inc., Lumenis Ltd., Biofrontera AG, and Leo Pharma A/S.Tier 1 players in the onychomycosis treatment market have a 37.3% market value share, and accounted for a market value of US$ 1.3 Bn in 2017. ©2015 Future Market Insights, All Rights Reserved 6 Onychomycosis Treatment Market Analysis Definition Onychomycosis, also called tinea unguium, is a fungal infection of the nails. The symptoms of onychomycosis include white or yellow nail discoloration, thickening of the nails, and separation of the nails from the nail bed. Complications include cellulitis of the lower legs. Onychomycosis is caused by a number of fungi such as dermatophytes, Candida (yeast), and nondermatophytic molds. Click here to Order a free sample ©2015 Future Market Insights, All Rights Reserved 7 To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: [email protected] For media queries, contact the press office at [email protected] For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: [email protected] Thank You Future Market Insights Global & Consulting Private Limited (FMI) ©2015 Future Market Insights, All Rights Reserved 8
There is an increasing trend of partnerships being witnessed among leading players in the onychomycosis treatment market. Companies are entering into marketing and sales agreements for their promotion of their products.
© Copyright 2024 Paperzz
